Optical biosensing based on gold nanoparticles supporting localized surface plasmoncs (LSPR) potentially offers great opportunities for compact, sensitive and low cost diagnostic devices. While last two decades have witnessed a diversity of nanoplasmonic systems with outstanding sensitivity, the implementation of LSPR sensing into a real analytical device is only at its infancy. In this context, we present here our latest advances in the optical, label free detection of biomolecules based on gold nanoantennas integrated into a state-of-the-art microfluidic platform. We first demonstrate the capability of our platform to detect low concentrations (<1ng/ml) of protein cancer markers in human serum with low unspecific binding and high repeatability. In a second step we present a novel design that enables to simultaneously determine the absolute concentration of four different target molecules from an unknown sample. The system is validated in the context of breast cancer, as a strategy to assess the risk for brain metastasis. In the final part of the paper we discuss the use of LSPR sensing for the detection of other targets, including DNA and exosomes. Our research demonstrates the high potential of gold nanoparticles for the detection of different biomarkers in real biological samples and thus gets us closer to future LSPR-based point-of-care devices.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the proceedings. They include the speaker's narration with video of the slides and animations. Most include full-text papers. Interactive, searchable transcripts and closed captioning are now available for 2018 presentations, with transcripts for prior recordings added daily.
Search our growing collection of more than 16,000 conference presentations, including many plenaries and keynotes.